Reuters: Health News: FDA rebuff deals big blow to Novo Nordisk's U.S. hopes

FDA rebuff deals big blow to Novo Nordisk's U.S. hopes

COPENHAGEN (Reuters) - U.S. regulators dealt a major blow to Novo Nordisk's hopes for its new long-acting insulin Tresiba by demanding the Danish drug...

Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/wRpclrIHt-M/us-novonordisk-tresiba-idUSBRE9190DK20130210